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           Infl  uenza viruses (IVs) may cause primary viral 
pneumonia in humans with fatal outcome as 
soon as the pathogen spreads from the upper 
respiratory tract to the alveolar air space, espe-
cially during infections with highly pathogenic 
IV. Early innate immune responses initiate the 
release of proinfl  ammatory chemokines and the 
recruitment of neutrophils, lymphocytes, and 
particularly mononuclear phagocytes into the 
alveolar air space to limit viral spread (  1  ). The 
mononuclear phagocyte system of the lung is 
composed of resident interstitial and alveolar 
macrophages (F4/80  +  CD11c  high  MHCII  low  ) and 
pulmonary DCs (F4/80  +  CD11c  high  MHCII  high  ), 
both derived from a common BM precursor 
(  2, 3  ). During lung infl  ammation and IV infec-
tion, peripheral blood monocytes (GR1  int  F4/
80  +  CD11c        CD11b  +  CD115  +  ) are recruited 
to the alveolar compartment of the lung via 
the interaction of CC-chemokine ligand 2 
(CCL2), which is released from alveolar epi-
thelial cells (AECs) with its monocytic receptor 
CC-chemokine receptor 2 (CCR2) (  1, 4  –  6  ). 
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  Mononuclear phagocytes have been attributed a crucial role in the host defense toward 
infl  uenza virus (IV), but their contribution to infl  uenza-induced lung failure is incompletely 
understood. We demonstrate for the fi  rst time that lung-recruited   “  exudate  ”   macrophages 
signifi  cantly contribute to alveolar epithelial cell (AEC) apoptosis by the release of tumor 
necrosis factor  –  related apoptosis-inducing ligand (TRAIL) in a murine model of infl  uenza-
induced pneumonia. Using CC-chemokine receptor 2  –  defi  cient (CCR2      /     ) mice character-
ized by defective infl  ammatory macrophage recruitment, and blocking anti-CCR2 
antibodies, we show that exudate macrophage accumulation in the lungs of infl  uenza-
infected mice is associated with pronounced AEC apoptosis and increased lung leakage and 
mortality. Among several proapoptotic mediators analyzed, TRAIL messenger RNA was 
found to be markedly up-regulated in alveolar exudate macrophages as compared with 
peripheral blood monocytes. Moreover, among the different alveolar-recruited leukocyte 
subsets, TRAIL protein was predominantly expressed on macrophages. Finally, abrogation of 
TRAIL signaling in exudate macrophages resulted in signifi  cantly reduced AEC apoptosis, 
attenuated lung leakage, and increased survival upon IV infection. Collectively, these fi  nd-
ings demonstrate a key role for exudate macrophages in the induction of alveolar leakage 
and mortality in IV pneumonia. Epithelial cell apoptosis induced by TRAIL-expressing 
macrophages is identifi  ed as a major underlying mechanism. 
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As shown in   Fig. 1 A  , only 17.3% of CCR2-defi  cient mice 
succumbed to PR/8 infection as compared with 78.4% of 
infected WT mice (P   <   0.005 on days 14  –  21 pi).   Likewise, 
body weight loss was signifi  cantly less in CCR2       /       mice on 
days 8, 9, and 11 pi. To evaluate whether the observed dif-
ferences in morbidity and mortality during PR/8 infection 
were associated with increased severity of lung injury in WT 
mice as compared with CCR2       /       mice, alveolar barrier 
function was assessed during a time course of 21 d after PR/8 
infection in the two treatment groups. Indeed, alveolar leak-
age was signifi  cantly reduced in CCR2-defi  cient mice on 
day 7 pi (1.25   ±   0.39 vs. 0.54   ±   0.37 arbitrary units;   Fig. 1 B  ), 
indicating that CCR2       /       mice develop less alveolar barrier 
damage upon PR/8 infection than WT mice. 
  During IV pneumonia, alveolar epithelial injury may be 
caused by direct cytopathic eff  ects of IV replicating primarily 
in epithelial cells. Therefore, we evaluated whether the ob-
served diff  erences in lung barrier damage between WT and 
CCR2       /       mice were linked to diff  erent viral replication ef-
fi  ciencies in the lung tissue of the two mouse strains. Analyses 
of viral replication in lung homogenates from PR/8-infected 
WT compared with CCR2       /       mice revealed no signifi  cant 
diff  erences in peak viral titers at days 2, 3, and 5 pi and even 
slightly elevated virus titers in CCR2       /       mice during the 
later stages of infection (1.05   ±   1.33   ×   10  3   vs. 6.20   ±   3.90   ×   
10  3   foci-forming units/lung on day 11 pi;   Fig. 1 C  ). These 
These   “  exudate  ”   macrophages acquire a lung resident mac-
rophage phenotype and fi  nally replenish the alveolar macro-
phage pool during the time course of infection (  7  ). 
  Besides their essential host defense functions, mononu-
clear phagocytes have been proposed to contribute to an im-
balanced detrimental immune response during IV pneumonia 
(  8, 9  ) and have been implicated in alveolar epithelial damage. 
Human IV pneumonia, which is characterized by rapid pro-
gression to lung failure and poor outcome, has gained in 
importance during the recent outbreaks in Southeast Asia. 
Infection with highly pathogenic IV causes signifi  cant tissue 
damage to the lungs with acute alveolitis followed by massive 
pulmonary edema and hemorrhage and extensive destruction 
of the respiratory epithelium (  10  –  12  ). However, the distinct 
molecular steps of macrophage  –  epithelial interaction during 
IV-induced acute lung injury remain elusive. 
  Several authors suggest AEC apoptosis to be an underly-
ing mechanism of alveolar damage in murine and human 
models of adult respiratory distress syndrome (  13  –  15  ). Death 
receptors and their ligands play an important role in the or-
chestration of innate and adaptive immune responses (  16  –  18  ). 
TNF-related apoptosis-inducing ligand (TRAIL) is a trans-
membrane protein belonging to the TNF superfamily. 
Among the members of this family, TRAIL exhibits the 
highest homology to Fas ligand (FasL), a well known inducer 
of programmed cell death (  18  ). Being expressed mainly on T 
cells, NK cells, and mononuclear phagocyte subsets, murine 
TRAIL exerts its proapoptotic signals via binding to DR5 
(death receptor 5) (  19  ) and displays potent antitumor activity 
(  20, 21  ). Recently, an antiviral function in experimental mu-
rine IV infection has been suggested (  18  ). However, the con-
tribution of TRAIL to alveolar epithelial apoptosis and lung 
barrier dysfunction during lethal IV pneumonia has not been 
elucidated yet. 
  In the present study, in a murine model of IV-induced 
acute lung injury, we demonstrate for the fi  rst time that exu-
date macrophages recruited via the CCL2-CCR2 axis largely 
contribute to AEC apoptosis involving the expression of 
TRAIL. Both blockade of the specifi  c chemokine-receptor 
axis and abrogation of macrophage TRAIL signaling by anti-
TRAIL mAb treatment or use of adoptively transferred mice 
recruiting TRAIL-defi   cient exudate macrophages signifi  -
cantly reduced alveolar epithelial apoptosis and lung leakage 
in infected mice, resulting in increased survival during other-
wise fatal IV pneumonia. 
    RESULTS   
  Genetic deletion of CCR2 reduces mortality, morbidity, 
and alveolar barrier dysfunction during PR/8 infection 
  Previous reports suggest that the chemokine receptor CCR2 
is critically involved in host immune responses to lung infec-
tion (  4, 22  –  24  ). To investigate the infl  uence of CCR2 on 
the course of IV pneumonia in mice, C57BL/6 WT and 
CCR2       /       mice were intratracheally inoculated with a lethal 
dose of the mouse-adapted IV strain PR/8, and survival and 
body weight were determined during the 21 d post infection (pi). 
    Figure 1.         CCR2 defi  ciency is associated with increased survival, 
reduced body weight loss, attenuated alveolar leakage, and slightly 
reduced viral clearance during the time course of PR/8 infection  . 
(A) Body weight and survival of PR/8-infected sex- and age-matched WT 
(   ,   n   = 23) or CCR2      /      (  ,   n   = 23) were determined until days 14 and 
21 pi, respectively in four independent experiments. Error bars show SD. 
(B) Alveolar leakage was analyzed in PR/8-infected WT (fi  lled bars) or 
CCR2      /      (empty bars) mice. The ratio of BALF and blood FITC fl  uorescence 
is expressed in arbitrary units (AU). (C) Lung virus titers of WT (   )  and 
CCR2      /      (   ) mice in the time course of PR/8 infection. Virus titers were 
determined from lung homogenate supernatants and values are given as 
log  10   foci-forming units (FFU)/lung. Data in B and C are means   ±   SD of 
three to fi  ve mice per group from at least three independent experiments. 
*, P   <   0.05; ***, P   <   0.005.     JEM VOL. 205, December 22, 2008 
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counts and cell diff  erentials were determined at various time 
points pi. No signifi  cant diff  erences in total BALF cell counts 
were detectable between the two treatment groups (  Fig. 2 A  ).   
Peak alveolar neutrophil accumulation was delayed in CCR2-
defi  cient mice and slightly exceeded values reached in WT 
mice on days 7 and 8 pi. Lymphocyte recruitment was vir-
tually identical in both treatment groups. Total numbers of 
resident alveolar macrophages in BALF were lower in CCR2-
defi  cient mice on days 5  –  9 pi but reached comparable levels 
during the later stages of infection. However, alveolar mono-
nuclear phagocyte recruitment was found to be strongly re-
duced in CCR2-defi  cient mice, most prominently at day 8 
results indicate that enhanced alveolar injury in WT mice 
during PR/8 pneumonia is not caused by higher viral repli-
cation rates than those in CCR2       /       mice and rather suggest 
that mononuclear phagocytes recruited to infl  amed tissues in 
a CCR2-dependent manner may directly cause alveolar dam-
age during IV pneumonia. 
  CCR2 defi  ciency selectively affects alveolar mononuclear 
phagocyte recruitment during IV pneumonia 
  To evaluate whether the amount and composition of alveolar 
leukocyte infi  ltration diff  er in PR/8-infected WT and CCR2       /       
mice, total bronchoalveolar lavage (BAL) fl  uid (BALF) cell 
    Figure 2.         Alveolar macrophage recruitment in PR/8-infected mice is CCR2 dependent.   (A and B) PR/8-infected WT (fi  lled bars) or CCR2      /     
(empty bars) mice were subjected to BAL, followed by quantifi  cation of total leukocyte BALF numbers (A) and BAL leukocyte subpopulations (B) from Pap-
penheim-stained cytocentrifuge preparations. (C) Quantifi  cation of exudate mononuclear phagocytes calculated from differential counts of BAL leuko-
cytes from infected WT mice treated with isotype IgG or anti-CCR2 mAb (day 8 pi, left). Alveolar leakage of isotype- or anti-CCR2 – treated  PR/8-infected 
mice (day 7 pi, right). (D) FACS analysis of alveolar mononuclear phagocyte subpopulations in BALF from infected WT versus CCR2      /      mice or from WT 
mice treated with isotype IgG or anti-CCR2 mAb was performed by three-hierarchy gating on day 8 pi. CD45  +   cells (population 1 [P1]) were gated accord-
ing to their GR1 and F4/80 expression. GR1  int F4/80 +   cells represent alveolar mononuclear phagocytes (population 2 [P2]). Subgate analysis of population 2 
revealed a CD11c  int   (population 3 [P3], exudate macrophages) and a CD11c  high   (population 4 [P4], resident AM) subpopulation as well as a CD11c  high -
MHCII  high   subpopulation (population 5 [P5]) representing alveolar DCs. (E) Flow cytometric quantifi  cation of CD11c  high MHCII high   DCs and lymphocyte sub-
populations from BAL leukocytes of PR/8-infected WT (fi  lled bars) versus CCR2      /      (empty bars) mice using the gating characteristics described in D for 
DCs. For analysis of lymphocyte subpopulations, CD45  +   cells were subgated on NK cells (SSC  low NK1.1 +  ), CD4 T cells (SSC  low CD4 +  ), and CD8 T cells 
(SSC  low CD8 +  ). Data in E are given as total cells in BAL calculated from the respective percentage of CD45  +   cells. All bar graphs represent the means   ±   SD 
from fi  ve experiments. *, P   <   0.05; ***, P   <   0.005. AM, alveolar macrophages; ex, exudate; mn, mononuclear; iso, isotype IgG.     3068 MACROPHAGES AND ALVEOLAR EPITHELIAL APOPTOSIS   | Herold et al. 
GR1 and F4/80 expression revealed three distinct cell popu-
lations: Gr1  high  F4/80         neutrophils, GR1        F4/80         lymphocytes, 
and GR1  int  F4/80  +   mononuclear phagocytes (population 2; 
  Fig. 2 D  , second column), which were composed of a CD11c  int   
(population 3, henceforth termed exudate macrophages) and 
pi (1.27   ±   0.35   ×   10  6   vs. 0.3   ±   0.21   ×   10  6  ;   Fig. 2 B  ). Corre-
spondingly, exudate mononuclear phagocyte numbers were 
signifi  cantly decreased in PR/8-infected WT mice pretreated 
with an anti-CCR2 mAb by day 8 pi (  Fig. 2 C  , left), which 
is associated with reduced alveolar leakage, as compared with 
isotype IgG-treated mice (  Fig. 2 C  , right), suggesting a key 
role of alveolar recruited mononuclear phagocytes in IV-in-
duced lung barrier breakdown. 
  To further dissect the alveolar mononuclear phagocyte 
subset composition, BALF cells gained from PR/8-infected 
mice of the various treatment groups were subjected to FACS 
analysis for surface marker expression at day 8 pi. Analysis of 
CD45  +   BALF cells (population 1;   Fig. 2 D  , fi  rst column) for 
    Figure 3.         Alveolar barrier dysfunction is associated with CCR2 
expression on circulating leukocytes during PR/8 infection.   (A)  Three 
different groups of PR/8-infected BM chimeric mice (WT recipient mice 
with transplantation of 100% WT BM cells; WT recipient mice with trans-
plantation of mixed 50% WT/ 50% CCR2      /      BM cells; and WT recipient 
mice with transplantation of 100% CCR2      /      BM cells) were subjected to 
BAL at day 8 pi. Exudate macrophage numbers were calculated from BALF 
leukocyte numbers and differential counts of Pappenheim-stained cyto-
centrifuge preparations. (B) FACS analysis of BALF cells from PR/8-in-
fected chimeric mice of each transplantation group was performed as 
described in   Fig. 2 D  , and representative dot plots from three independent 
experiments are shown. Note that population 3 (P3; exudate macro-
phages), population 4 (P4; resident alveolar macrophages), and popula-
tion 5 (P5; alveolar DCs) are subgates of population 2 [P2]. (C) Alveolar 
leakage from PR/8-infected chimeric mice at day 7 pi. All bar graphs rep-
resent the means   ±   SD of four to eight mice per group from three inde-
pendent experiments. ***, P   <   0.005.     
    Figure 4.         AEC apoptosis is reduced in PR/8-infected CCR2      /      mice 
compared with WT mice.   (A) WT or CCR2      /      mice were mock or PR/8 
infected and TUNEL assay was performed on cryosections from lavaged 
lungs at day 7 pi. Nuclei of apoptotic cells appear in brown. Arrows, apop-
totic intraalveolar leukocytes; arrowheads, apoptotic AEC. Bars, 100   μ  m. 
(B) Flow cytometric quantifi  cation of apoptotic AEC. Lungs from mock- or 
PR/8-infected WT or CCR2      /      mice were digested on day 7 pi and ana-
lyzed for annexin V binding. Representative dot plots show expression of 
the AEC type I marker T1      and annexin V staining of viable (propidium 
iodide negative) CD45         cells. Apoptotic cells are mainly AEC type I (left). 
Quantifi  cation of FACS data as obtained in B from PR/8-infected mice 
(right). The bar graph represents the annexin V  +   proportion of CD45        
T1     +   cells. (C) Quantifi  cation of FACS analysis of the NP  +   proportion  of 
CD45         T1    +   cells from lung homogenates in the time course after PR/8 
infection. Values are means   ±   SD of three to four mice per group from 
three independent experiments. *, P   <   0.05; ***, P   <   0.005. NP, IV nucleo-
protein; fi  lled bars, WT; empty bars, CCR2      /    .   JEM VOL. 205, December 22, 2008 
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pared with mice after transplantation of 100% WT BM (  Fig. 
3 C  ). These results clearly demonstrate that CCR2 expressed 
on circulating blood monocytes is critically involved in 
mononuclear phagocyte extravasation into the alveolar com-
partment of the lung, thereby contributing to alveolar bar-
rier dysfunction during IV pneumonia. 
  CCR2-dependent alveolar exudate macrophage 
accumulation is associated with increased AEC apoptosis 
  Given that the CCR2-dependent accumulation of exudate 
macrophages in IV pneumonia contributed to the loss of al-
veolar barrier integrity, we hypothesized that this recruited 
mononuclear cell population might promote barrier dysfunc-
tion by inducing AEC apoptosis. Therefore, cryosections 
from lavaged lungs of mock- or PR/8-infected WT or 
CCR2-defi  cient mice were subjected to TUNEL assay. As 
shown in   Fig. 4 A  , the number of apoptotic alveolar cells was 
strikingly less in PR/8-infected CCR2       /       mice as compared 
with WT mice, and virtually undetectable in mock-infected 
a CD11c  high   (population 4) subpopulation, representing resi-
dent alveolar macrophages according to previous reports (  2, 3  ). 
Exudate macrophages (population 3) accumulated to a much 
lesser extent in CCR2       /       mice or in mice pretreated with 
anti-CCR2 antibody as compared with WT mice or isotype 
IgG-treated mice, respectively (  Fig. 2 D  , third column). Al-
veolar mononuclear phagocytes (population 2) contained a 
low proportion of DCs (CD11c  +  MHCII  high   [population 5 
(P5)];   Fig. 2 D  , fourth column). Alveolar DC recruitment 
was delayed in PR/8-infected CCR2       /       mice but reached 
peak values comparable to those of WT mice by day 8 pi 
(  Fig. 2 E  , top left). Flow cytometric analysis of alveolar lym-
phocyte subsets revealed no striking diff  erences in the re-
cruitment of CD4  +   T cells or CD8  +   T cells between WT and 
CCR2-defi  cient mice at the given time points, whereas al-
veolar NK cell accumulation peaked earlier at day 5 pi in 
CCR2       /       mice (  Fig. 2 E  ). Analysis of interstitial exudate 
macrophage accumulation in PR/8-infected lungs revealed 
faster recruitment kinetics than in the alveolar compartment 
but was likewise signifi  cantly reduced in mice lacking CCR2 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20080201/DC1). Altogether, our data demonstrate that re-
cruitment of GR1  int  F4/80  +  CD11c  int  MHCII  low   exudate macro-
phages into the lungs during PR/8 pneumonia was severely 
impaired in CCR2-defi  cient mice or WT animals treated 
with function blocking anti-CCR2 antibodies. 
  CCR2 expression on circulating leukocytes, but not on lung 
resident cells, is associated with alveolar barrier dysfunction 
during PR/8 infection 
  To distinguish whether CCR2 expressed on resident lung cells, 
such as resident alveolar macrophages or AEC, or CCR2 
present on circulating leukocytes accounted for the increased 
IV-induced alveolar leakage in WT versus CCR2       /       mice, 
we made use of a BM chimeric mouse model. We established 
three diff  erent transplantation groups: (a) WT mice with trans-
plantation of 100% WT BM cells; (b) WT mice with trans-
plantation of a mixture of WT and CCR2       /       BM cells (50% 
WT/50% CCR2       /      ); and (c) WT mice with transplantation 
of 100% CCR2       /       BM cells. CCR2 expression on F4/80  +   
peripheral blood monocytes was analyzed 14 d after trans-
plantation by fl  ow cytometry and corresponded to the re-
spective proportion of transplanted WT or CCR2       /       BM 
cells in the diff  erent transplantation groups, whereas resident 
alveolar macrophages homogeneously displayed a WT phe-
notype as previously outlined in detail (  25  ) (unpublished data). 
Exudate macrophage accumulation on day 8 after PR/8 infec-
tion in transplanted mice was dependent on the proportion 
of peripheral blood monocytes with intact CCR2 expres-
sion, with mice after transplantation of WT BM recruiting 
0.85   ±   0.27   ×   10  6  , mice after transplantation of mixed BM 
recruiting 0.57   ±   0.29   ×   10  6  , and mice after transplantation 
of CCR2       /       BM recruiting a total of 0.24   ±   0.09   ×   10  6   exu-
date macrophages into the alveolar compartment (  Fig. 3, A 
and B  ).   Notably, alveolar leakage at day 7 pi was signifi  cantly 
reduced in mice after transplantation of CCR2       /       BM com-
    Figure 5.         Relative mRNA expression of the proapoptotic factors 
TNF-    , TRAIL, and FasL in peripheral blood (PB) monocytes and al-
veolar exudate macrophages.   (A) BALF exudate alveolar macrophages 
from PR/8-infected WT mice were high-purity fl  ow sorted on day 8 pi 
according to their surface expression of F4/80, GR1, and CD11c (F4/
80  + GR1 int CD11c int   [population 3 (P3)], left). PB monocytes from the same 
(PR/8 infected) animals or from mock-infected mice were fl  ow sorted ac-
cording to their scatter characteristics (SSC  low  ) and CD11b and CD115 expres-
sion (CD11b  + CD115 +   [population 3 (P3)], right). SSC, side scatter; FSC, 
forward scatter. (B) Relative mRNA expression of TNF-     , TRAIL, and FasL 
from sorted PB monocytes of mock-infected (PB-Mo mock) or PR/8-infected 
(PB-Mo PR/8) mice or from exudate macrophages of infected mice 
(ExMa PR/8). Values are the means   ±   SD from three independent experiments, 
including pooled BALF or blood cells, from   n   = 8 mice each. *, P   <   0.05.    3070 MACROPHAGES AND ALVEOLAR EPITHELIAL APOPTOSIS   | Herold et al. 
  Alveolar exudate macrophages up-regulate messenger RNA 
(mRNA) levels of proapoptotic TRAIL as compared 
with peripheral blood monocytes 
  To analyze mRNA levels of potential proapoptotic factors in 
alveolar exudate macrophages and their blood precursors, pe-
ripheral blood monocytes from mock-infected or PR/8-in-
fected WT mice, as well as alveolar exudate macrophages 
from PR/8-infected WT mice, were fl  ow sorted on day 8 pi 
according to scatter and surface marker characteristics as 
shown in   Fig. 5 A   and analyzed for TNF-     , TRAIL, and 
FasL transcripts using quantitative RT-PCR.  TNF-      mRNA 
transcripts were found to be signifi  cantly increased to the 
same level in both peripheral blood monocytes and alveolar 
exudate macrophages from PR/8-infected mice as compared 
with blood monocytes from mock infected mice (  Fig. 5 B  , 
left). However, TNF-      protein levels in BALF did not sig-
nifi  cantly diff  er between PR/8-infected WT and CCR2-de-
fi  cient mice on day 7 pi (348   ±   65 and 266   ±   113pg/ml, 
mice.   For apoptosis quantifi  cation of AEC type I represent-
ing the major component of the alveolar surface, lung ho-
mogenates of the respective treatment groups were subjected 
to fl  ow cytometry, and CD45         cells were analyzed for an-
nexin V binding and expression of the AEC type I marker 
T1     . Representative dot plots in   Fig. 4 B   (left) demonstrate 
a signifi  cantly larger proportion of type I AEC to undergo 
apoptosis in lung homogenates of PR/8-infected WT mice 
than in PR/8-infected CCR2-defi  cient mice at day 7 pi. 
Flow cytometric quantifi  cation during the time course of in-
fection revealed a sustained increase of type I AEC apoptosis 
in WT compared with CCR2       /       mice throughout days 7  –  11 
pi corresponding to the kinetics of alveolar exudate macro-
phage accumulation (  Fig. 4 B  , right). The proportions of 
infected (IV nucleoprotein  +  ) type I AEC were virtually iden-
tical in both WT and CCR2-defi  cient mice, with direct viral 
cytopathic eff  ects most likely accounting for the observed 
type I AEC apoptosis rate that was still present in CCR2       /       
mice (  Fig. 4, B and C  ). No diff  erences in CD45        CD31  +   
lung endothelial cell apoptosis could be detected during days 
5  –  14 in PR/8-infected WT compared with CCR2       /       mice 
(unpublished data). 
    Figure 6.         TRAIL is expressed on the cell surface of alveolar exu-
date macrophages.   (A) WT or CCR2      /      mice were mock or PR/8 infected 
and BAL cells were stained with GR1-FITC, F4/80  –  Alexa Fluor 647, and 
TRAIL PE or isotype PE mAbs, respectively. GR1  int F4/80 +   cells were gated 
and analyzed for TRAIL surface expression (left). Quantitative analysis of 
the proportion of TRAIL  +   from  F4/80 +   BALF cells gained from PR/8-in-
fected WT (fi  lled bars) or CCR2      /      mice (empty bars) on days 5, 8, and 
11 pi (right). (B) FACS analysis of TRAIL expression on BALF NK cells 
(SSC  low NK1.1 +  ), neutrophils (GR1  high F4/80 +  ), CD8 T cells (SSC  low CD8 + ),  and 
CD4 T cells (SSC  low CD4 +  ) of PR/8-infected WT (top) or CCR2      /      (bottom) 
mice gained at the indicated time points. Values are the means   ±   SD of 
two to four mice per group from at least two independent experiments. 
***,  P   <   0.005.   
    Figure 7.         x31-infected WT and CCR2      /      mice lack TRAIL expres-
sion on exudate macrophages and reveal equal levels of AEC apop-
tosis and alveolar barrier function.   (A)  Quantifi  cation of BAL exudate 
mononuclear phagocytes from Pappenheim-stained cytocentrifuge prep-
arations in x31-infected WT (fi  lled bars) or CCR2      /      (empty bars) mice. 
(B) Alveolar leakage of uninfected (day 0) or x31-infected (day 7) WT (fi  lled 
bars) or CCR2      /      (empty bars) mice. (C, right) FACS analysis of apoptotic 
AEC type I from mock- or x31-infected WT or CCR2      /      mice on day 7 pi. 
(C, left) Quantifi  cation of FACS data. Bar graphs show the annexin V  +  
proportion of CD45         T1    +   cells. (D) GR1  int F4/80 +   BAL cells from x31-in-
fected WT or CCR2      /      mice were gated and analyzed for TRAIL surface 
expression. *, P   <   0.05; ***, P   <   0.005. All bar graphs represent the means   ±   
SD from three independent experiments.     JEM VOL. 205, December 22, 2008 
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  Anti-TRAIL treatment attenuates alveolar epithelial 
apoptosis, as well as lung leakage, and enhances survival 
after PR/8 infection 
  To evaluate the contribution of exudate macrophage TRAIL 
to alveolar epithelial apoptosis, TUNEL assay was performed 
on cryosections of lavaged lungs from PR/8-infected WT mice 
treated with isotype IgG or anti-TRAIL mAb. Alveolar exu-
date macrophage numbers in anti-TRAIL  –   or IgG-treated 
mice were comparable to those of untreated mice upon PR/8 
infection (IgG, 1.97   ±   0.25   ×   10  6  ; anti-TRAIL, 1.83   ±   0.77   ×   
10  6  ). As shown in   Fig. 8 A  , alveolar cell apoptosis was pro-
nounced in isotype IgG-treated mice but signifi  cantly de-
creased in anti-TRAIL  –  treated mice on day 7 after PR/8 
infection.   In addition, anti-TRAIL treatment signifi  cantly 
reduced annexin V binding of AEC type I in PR/8-infected 
lung homogenates as compared with isotype IgG-treated 
controls (  Fig. 8 B  ). Analysis of alveolar barrier function in 
anti-TRAIL  –  treated PR/8-infected WT mice revealed a sig-
nifi  cant decrease in alveolar leakage in comparison to isotype 
IgG-treated control mice on day 7 pi (  Fig. 8 C  ). Reduction 
of alveolar leakage in anti-TRAIL  –  treated mice was associ-
ated with signifi  cantly increased survival of IV infection as 
compared with isotype-treated controls (  Fig. 8 D  ), although 
viral clearance from PR/8-infected lungs was substantially 
delayed upon anti-TRAIL treatment in comparison to un-
treated WT mice (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20080201/DC1). These data clearly dem-
onstrate a crucial role of TRAIL expressed by alveolar exu-
date macrophages, as opposed to direct viral cytopathic eff  ects, 
in the development of alveolar barrier dysfunction as a major 
determinant of mortality during IV pneumonia in mice. 
  Interestingly, TRAIL receptor (DR5) mRNA transcripts 
were found to be present in cultured primary murine AEC and 
were up-regulated upon PR/8 infection in a dose-dependent 
manner in vitro (  Fig. 8 E  ). Moreover, DR5 was present on 
type I AEC and further up-regulated on the infected (NP  +  ) 
proportion on day 5 pi in vivo (  Fig. 8 F  , left). Increased DR5 
expression persisted on NP  +   compared with NP         type I AEC 
until NP detection was lost by day 14 pi (  Fig. 8 F  , right), sug-
gesting an enhancing eff  ect of viral infection for macrophage 
TRAIL-mediated alveolar injury. 
  AEC apoptosis and leakage are attenuated in PR/8-infected 
mice recruiting TRAIL-defi  cient exudate macrophages 
to the alveolar air space 
  To strengthen the hypothesis that alveolar exudate macro-
phage accumulation mediates TRAIL-induced injury in PR/8 
pneumonia, the following BM chimeric mice were PR/8 
infected 2 wk after transplantation and analyzed for epithelial 
apoptosis and barrier dysfunction: (a) WT mice with trans-
plantation of WT BM; (b) WT mice with transplantation of 
TRAIL       /       BM; and (c) TRAIL       /       mice with transplanta-
tion of WT BM. Indeed, mice that were transplanted with 
TRAIL-defi  cient BM displayed reduced alveolar AEC type I 
apoptosis (  Fig. 9 A  ) and signifi  cantly reduced alveolar leakage 
on day 7 pi (  Fig. 9 B  ) compared with mice that were transplanted 
respectively; unpublished data), suggesting that exudate mac-
rophages recruited to the alveolar space in WT but less in 
CCR2       /       mice were not the primary source of TNF-     . No 
signifi  cant up-regulation of FasL mRNA could be detected 
in the analyzed cell populations (  Fig. 5 B  , middle). In con-
trast, TRAIL mRNA was selectively up-regulated fourfold 
in exudate macrophages as compared with their peripheral 
blood precursors from either mock- or PR/8-infected mice 
(  Fig. 5 B  , right). 
  TRAIL expression in the alveolar space is largely restricted 
to alveolar exudate macrophages during PR/8 infection 
  To evaluate TRAIL protein expression on the surface of al-
veolar mononuclear phagocytes, BALF cells from mock- or 
PR/8-infected WT or CCR2       /       mice were analyzed by 
fl  ow cytometry for F4/80 and TRAIL coexpression by day 
8 pi. TRAIL was exclusively found on F4/80  +   BALF cells 
from PR/8-infected WT but not CCR2-defi  cient mice, 
indicating that only CCR2 dependently recruited exudate 
macrophages but not resident alveolar macrophages ex-
pressed TRAIL (  Fig. 6 A  , left).   The proportion of TRAIL  +   
alveolar mononuclear phagocytes (F4/80  +  ) raised to     14% 
in PR/8-infected WT mice on day 8 pi and was always 
  <  1.5% in CCR2-defi  cient mice in the time course of infec-
tion (  Fig. 6 A  , right). As opposed to previous reports (  18  ), 
in our model, TRAIL was only expressed on a small pro-
portion of alveolar NK cells (WT, 5.6%; CCR2       /      , 5.2%) 
and was absent on alveolar CD4  +   and CD8  +   T cells as well 
as on alveolar neutrophils from both WT and CCR2       /       
mice at the indicated time points (  Fig. 6 B  ). In addition, 
TRAIL was undetectable on each of these leukocyte popu-
lations including monocytes in peripheral blood (unpub-
lished data). 
  Absence of TRAIL on alveolar exudate macrophages in x31-
infected mice is associated with preservation of alveolar 
barrier function 
  Given that PR/8 is highly virulent in mice, we questioned 
whether exudate macrophages would also act pro-apoptoti-
cally toward AECs upon a less severe viral lung infection. 
Therefore, we infected WT and CCR2-defi  cient mice with 
a less pathogenic IV strain, x31, at a nonlethal dose. Upon 
x31 infection, exudate macrophages accumulated in the alve-
olar air spaces of WT mice (yet to a lower extent than upon 
PR/8 infection) and were signifi  cantly reduced in the BALF 
of CCR2       /       mice (  Fig. 7 A  ).   However, in contrast to PR/8 
infection, x31 induced only a mild alveolar leakage on day 7 
pi without diff  erences between WT and CCR2-defi  cient 
mice (  Fig. 7 B  ). Accordingly, AEC type I apoptosis was pres-
ent on day 7 pi (    25%) but no diff  erences were detectable 
between the two mouse strains (  Fig. 7 C  ). Interestingly, this was 
correlated to the absence of TRAIL expression on F4/80  +   
alveolar mononuclear phagocytes in x31-infected WT mice 
(  Fig. 7 D  ), indicating that the induction of TRAIL on exu-
date macrophages is linked to more severe alveolar infl  amma-
tion as observed in PR/8 infection. 3072 MACROPHAGES AND ALVEOLAR EPITHELIAL APOPTOSIS   | Herold et al. 
with TRAIL  +/+   BM, with mice of all transplantation groups 
recruiting comparable alveolar exudate macrophage numbers 
(not depicted).   Inhibition of alveolar exudate macrophage re-
cruitment by anti-CCR2 antibodies signifi  cantly reduced al-
veolar leakage in mice after transplantation of WT (TRAIL  +/+  ) 
    Figure 8.         Anti-TRAIL treatment attenuates AEC apoptosis as well 
as alveolar leakage and enhances survival upon PR/8 infection.  
(A) PR/8-infected WT mice were treated with IgG isotype or anti-TRAIL 
mAb on days 3 and 5 pi and TUNEL assay was performed on lung cryosec-
tions at day 7 pi (arrows, apoptotic intraalveolar leukocytes; arrowheads, 
apoptotic AECs). Bars, 100   μ  m. (B) FACS analysis (representative dot plots, 
left) and quantifi  cation (four to six mice per group; right) of apoptotic 
AEC I of PR/8-infected, IgG isotype  –  treated, or anti-TRAIL  –  treated mice 
(day 7 pi). Error bars show SD. (C) Alveolar leakage of PR/8-infected WT 
mice at day 7 pi that were treated with IgG isotype or anti-TRAIL mAb at 
days 3 and 5 pi. (D) Survival of PR/8-infected WT mice treated with iso-
type IgG (   ,   n   = 10) or anti-TRAIL mAb (   ,   n   = 12) at days 3, 5, 7, and 9 
pi in three independent experiments. (E) TRAIL receptor DR5 is expressed 
on cultured AEC and up-regulated upon PR/8 infection dose dependently 
in vitro. Bar graphs depict DR5 mRNA expression as fold induction of 
mock-infected AEC. (F) DR5 is expressed on AEC and up-regulated upon 
PR/8 infection in vivo  .   Left, FACS analysis of DR5 and NP expression of 
gated AEC type I (CD45         T1    +  ) from digested lungs of uninfected (day 0, 
top) or PR/8-infected (day 5 pi) WT mice. Right, histograms depict DR5 
expression of NP-negative (medium gray histograms) and NP-positive 
CD45         T1    +   AEC I (dark gray histograms) from noninfected (day 0) and 
PR/8-infected WT mice in the time course of infection. Isotype PE  –  stained 
cells are shown in light gray histograms. An NP-positive population is 
missing at days 0 and 14 pi. Bar graphs in C and E represent the means   ±   
SD of three to fi  ve independent experiments. *, P   <   0.05; ***, P   <   0.005; 
iso, isotype IgG; NP, IV nucleoprotein.     
    Figure 9.         AEC apoptosis and lung leakage are reduced in PR/8-
infected mice recruiting TRAIL-defi  cient exudate macrophages to 
their lungs.   (A) Digested lungs of three different groups of PR/8-infected 
BM chimeric mice (WT recipient mice with transplantation of WT BM cells; 
WT recipient mice with transplantation of TRAIL      /      BM cells; and 
TRAIL      /      recipient mice with transplantation of WT BM cells) were ana-
lyzed for AEC type I apoptosis (left, representative FACS plots; right, quan-
titative analysis of fi  ve independent experiments). Error bars show SD. 
(B) Alveolar leakage of different BM chimeric mice that were either left 
untreated or injected with isotype IgG or anti-CCR2 mAb, respectively, 
was analyzed at day 7 pi. (C) CCR2      /      mice were adoptively transferred 
with CCR2  +/+ /TRAIL +/+ ,  CCR2 +/+ /TRAIL     /     , or CCR2      /    /TRAIL +/+   MNC, and 
alveolar leakage was analyzed at day 7 after PR/8 infection. BMT, BM 
transplantation; iso, isotype IgG; MNC, mononuclear cells; ***, P   <   0.005; 
*, P   <   0.05. Bar graphs in B and C represent the means   ±   SD of three to 
fi  ve mice per group from three independent experiments.     JEM VOL. 205, December 22, 2008 
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(MCP-1), CCR2 mediates the egress of GR1  +   monocytes 
from the BM and their recruitment from peripheral blood to 
sites of infection (  1, 23, 24, 31  –  33  ). In our own previous 
studies, we demonstrated that monocyte transmigration upon 
epithelial PR/8 infection in vitro was strictly dependent on 
the CCL2-CCR2 axis (  4  ). Thus, we assumed that the reduced 
lung leakage and mortality observed in CCR2-defi  cient mice 
during IV infection might be attributed to abrogated pulmo-
nary macrophage accumulation. In fact, as demonstrated by 
the use of chimeric mice, loss of alveolar barrier function was 
solely dependent on CCR2 expression on circulating mono-
cytes, indicating that mononuclear phagocyte traffi   c was crit-
ically involved and that CCR2-positive resident lung cell 
populations did not contribute to increased lung permeability 
in our model. Interestingly, a reduction of lung macrophage 
recruitment by 50% resulted in an approximately fi  vefold de-
crease in alveolar leakage, suggesting that alveolar damage 
only occurs beyond a critical threshold of macrophage accu-
mulation and that partial inhibition of macrophage recruit-
ment during IV pneumonia may strongly attenuate lung injury 
while presumably maintaining critical macrophage host de-
fense functions. 
  Several authors demonstrated both release of GR1  +   
monocytes from the BM into the circulation and their in-
fl  ammatory organ recruitment to be CCR2 dependent, with 
CCR2       /       mice exhibiting diminished peripheral blood mono-
cyte counts (  32, 33  ). Accordingly, GR1  +   peripheral blood 
monocytes were revealed to be     50% less in PR/8-infected 
CCR2-defi  cient mice and in anti-CCR2 mAb  –  treated mice 
in our study (unpublished data), confi  rming the aforemen-
tioned data and supporting the concept of CCR2 involvement 
in distinct steps of monocyte homeostasis under infl  ammatory 
and noninfl  ammatory conditions. Additionally, direct antibody-
mediated cytotoxicity might account for reduced GR1  +   
blood monocyte numbers in anti-CCR2 mAb  –  treated mice 
(  34  ). Therefore, a contribution of reduced circulating mono-
cyte numbers to the attenuation of acute lung injury in IV 
pneumonia cannot be totally excluded. 
  CCR2 defi  ciency was found to be associated with a slight 
but signifi  cant delay in viral clearance, confi  rming observa-
tions reported previously by Dawson et al. (  1  ) who suggest 
delayed adaptive immune responses as the underlying mecha-
nism. However, we were not able to detect signifi  cant diff  er-
ences in the alveolar accumulation of CD4  +   or CD8  +   T 
lymphocytes despite the observed delay in DC recruitment, 
which is known as the major APC population. Ongoing IV 
replication in CCR2       /       mice seemingly had no eff  ect on al-
veolar epithelial integrity. In fact, epithelial apoptosis oc-
curred when exudate macrophages were alveolar recruited in 
PR/8-infected WT mice between days 7 and 14 pi. This 
correlated with the bulk of mortality that was observed when 
virus titers were already reduced     100-fold and IV nucleo-
protein detection in AECs declined. These data support the 
concept that macrophage-mediated immune pathology ac-
counts for the severity of PR/8-induced lung injury in WT 
mice. Correspondingly, in a milder nonlethal model of IV 
but not in mice after transplantation of TRAIL       /       BM. 
These data indicate that TRAIL expression on grafted and 
then CCR2 dependently recruited cells rather than on lung 
resident cells is linked to lung injury. In addition, in an adop-
tive transfer approach using CCR2       /       recipient mice that were 
either transferred TRAIL  +/+  /CCR2  +/+  , TRAIL       /      /CCR2  +/+  , 
or TRAIL  +/+  /CCR2       /       mononuclear cells, alveolar leakage 
was assessed upon PR/8 infection. In this model, CCR2-defi  -
cient recipient mice will largely recruit adoptively transferred 
CCR2  +/+   monocytes into their lungs. As shown in   Fig. 9 C  , 
alveolar leakage at day 7 pi was signifi  cantly less in mice re-
cruiting TRAIL-defi   cient compared with mice recruiting 
TRAIL  +/+   exudate macrophages, with comparable alveolar 
exudate macrophage numbers in both treatment groups at 
day 7 pi (TRAIL  +/+  /CCR2  +/+   MNC, 5.79   ±   1.02   ×   10  5  ; 
TRAIL       /      /CCR2  +/+   MNC, 4.87   ±   1.48   ×   10  5  ). Recipient 
mice that were transferred CCR2       /       MNC recruited only 
1.62   ±   0.99   ×   10  5   exudate macrophages and correspondingly 
demonstrated low leakage. These data clearly demonstrate that 
TRAIL-induced lung injury in PR/8 pneumonia is medi-
ated by alveolar recruitment of TRAIL  +/+   but not TRAIL       /       
exudate macrophages. 
    DISCUSSION   
  IV pneumonia is characterized by the rapid development of 
acute lung injury with a poor outcome. One of the hallmarks 
of acute lung injury is an incremental alveolar barrier dys-
function followed by accumulation of protein-rich edema 
fl  uid in the alveolar compartment (  12, 26, 27  ). Both viral 
pathogenicity factors and imbalanced host immune responses 
have been attributed a role in IV-induced lung failure (  28  –  30  ). 
However, the molecular cross talk between immune and 
lung structural cell populations that leads to severe immuno-
pathology and organ dysfunction is largely unknown. 
  Therefore, we tested the hypothesis that exudate macro-
phages, recruited to the lung in a CCL2/CCR2-dependent 
manner, might contribute to lung barrier dysfunction during le-
thal IV infection. In fact, alveolar barrier function, which is 
severely aff  ected in IV-infected WT mice, was found to be 
signifi  cantly improved in CCR2-defi  cient mice exhibiting de-
fective exudate macrophage recruitment. Consequently, CCR2 
defi  ciency was associated with drastically decreased mortality 
during experimental IV pneumonia. Moreover, the pronounced 
lung leakage observed in WT mice correlated with an increased 
AEC apoptosis rate found to be induced by TRAIL, which is 
predominantly expressed in exudate lung macrophages. Finally, 
treatment of IV-infected WT mice with an anti-TRAIL mAb 
or use of mice recruiting TRAIL-defi  cient exudate macrophages 
not only attenuated alveolar leakage but signifi  cantly reduced 
mortality from IV pneumonia. Collectively, these results dem-
onstrate that macrophage recruitment to IV-infected lungs in 
mice exerts detrimental eff  ects on lung parenchymal cells of the 
highly sensitive gas exchange compartment severely aff  ecting al-
veolar barrier function via TRAIL-induced epithelial apoptosis. 
  CCR2 is known to play a crucial role in host defense 
against pathogens. Interacting with its primary ligand CCL2 3074 MACROPHAGES AND ALVEOLAR EPITHELIAL APOPTOSIS   | Herold et al. 
Consistent with this, the number of infected (NP  +  ) AECs 
was only slightly reduced in WT compared with CCR2       /       
mice on days 11 and 14 pi, indicating only partial selectivity 
of TRAIL-mediated killing between infected and noninfected 
cells. These data suggest that, upon such conditions, the de-
structive eff  ects of TRAIL prevail over its antiviral function 
thereby leading to enhanced lung injury and mortality. 
  A recent study (  40  ) confi  rms the concept that monocyte-
derived cells signifi   cantly contribute to immunopathology 
and lung injury in PR/8 pneumonia, but the authors suggest 
the underlying mechanism to be an increased production of 
inducible nitric oxide synthase and TNF-     . Regarding TNF-
      release, we could not detect signifi  cant diff  erences in alve-
olar-secreted TNF-     during the time course after PR/8 infection 
in WT and CCR2-defi  cient mice (unpublished data). As 
previously published by Akaike et al. (  41  ), reactive oxygen 
and nitrogen species have been detected in the alveolar fl  uid 
of IV infected mice, and macrophages and neutrophils were 
identifi  ed as the primary source. Although Lin et al. (  40  ) did 
not provide direct evidence that monocyte/macrophage-de-
rived reactive nitrogen species accounted for the observed 
lung damage in their model, it is conceivable that macro-
phage-released proinfl  ammatory mediators additionally con-
tribute to lung injury in IV pneumonia. 
  Altogether, our study demonstrates for the fi  rst time a key 
role of exudate macrophage TRAIL in AEC apoptosis promot-
ing alveolar barrier dysfunction during IV lung infection. No-
tably, inhibition of TRAIL activity largely protected mice from 
lethal IV pneumonia. Targeting the TRAIL  –  DR5 pathway 
might therefore be a suitable tool for restoring lung epithelial 
function in patients suff  ering from severe IV pneumonia. 
  MATERIALS AND METHODS 
  Reagents.     The following anti  –  mouse mAbs/secondary reagents were used 
for fl  ow cytometry: CD45.2-FITC and CD45.2-PerCP-Cy5.5 (30F-11), 
CD45.1-PE (A20), GR1-PE and GR1-FITC (RB6-8C5), GR1-PE-Cy7 
(RB6-8C5), biotinylated I-A/I-E (2G9), NK1.1-APC (PK136), CD4-FITC 
(RM4-4), biotinylated CD8-      (53  –  6.7), CD11c-PE (HL3), CD11b-FITC 
(M1/70), SA-APC-Cy7, biotinylated F(ab     )  2   anti  –  mouse Ig, Streptavidin-
PE, isotype-matched control IgG antibodies (all BD), F4/80  –  Alexa Fluor 
647 (CI:A3-1; Invitrogen), F4/80  –  Alexa Fluor 488 (BM8; Invitrogen), 
CD11c-PE-Cy5.5 (418; Invitrogen), CD115-PE (MCA1898; AbD Sero-
tec), T1     /Podoplanin/gp36 (Abcam), TRAIL-PE (N2B2; BioLegend), 
TRAIL R2 (DR5)  –  PE (118929; R  &  D Systems), isotype-PE (rat IgG2a     ; 
BioLegend), antiinfl  uenza NP (Meridian Life Science, Inc.), annexin V  –  Al-
exa Fluor 647, anti  –  hamster Ig Alexa Fluor 488, and anti  –  mouse Ig Alexa 
Fluor 647 (all Invitrogen). 150   μ  g of low endotoxin/azide-free anti-TRAIL 
mAb (N2B2; IgG2a; BioLegend) in 150   μ  l PBS       /       was applied i.p. at days 
3, 5, 7, and 9 pi, and 75   μ  g of rat anti  –  mouse CCR2 mAb (IgG2b; gift from 
M. Mack, University of Regensburg, Regensburg, Germany) in 100   μ  l 
PBS       /       was applied i.p. at days 0 and 4 pi (  42  ). Respective isotype control 
IgG Abs (IgG2a [BioLegend] and IgG2b [BD]) were applied at the same 
concentrations. Propidium iodide was purchased from Sigma-Aldrich. 
  Mice.     C57BL/6 WT mice were purchased from Charles River Laborato-
ries. CCR2-defi  cient mice were generated as described previously and back-
crossed to the C57BL/6 background (  43  ). B6.SJL-  Ptprc  a     mice expressing the 
CD45.1 alloantigen (Ly5.1 PTP) on circulating leukocytes (C57BL/6 
genetic background) were obtained from The Jackson Laboratory. TRAIL-
defi  cient mice (C57BL/6 genetic background) were a gift from Amgen. 
infection (x31) where exudate macrophage numbers were 
    75% lower than in PR/8-infected WT mice, lung injury 
was considerably less pronounced, emphasizing the predomi-
nant role of host immune responses in IV-induced pathology. 
  Alveolar epithelial apoptosis has been described as a com-
mon feature of acute lung injury caused by direct or indirect 
factors such as pneumonia, aspiration, sepsis, or trauma (  13  –  15  ). 
Apoptosis is a regulated form of cell death that is mediated by 
membrane death receptors (extrinsic pathway) and direct mi-
tochondrial injury (intrinsic pathway). Apoptosis has been 
described to occur in the lungs of patients with acute lung 
injury by activation of the epithelial membrane Fas death re-
ceptor by soluble FasL, released from invading leukocytes 
and accumulating in a biologically active form at the onset of 
lung injury (  35, 36  ). However, in our model of IV-induced 
acute lung injury, FasL transcripts were not diff  erentially reg-
ulated in the macrophage subsets analyzed. In contrast, the 
proapoptotic molecule TRAIL not expressed in peripheral 
blood monocytes was found to be strongly up-regulated in 
exudate macrophages recruited into the alveolar space in IV-
infected WT mice, whereas TRAIL was undetectable in the 
alveolar mononuclear phagocytes of IV-infected CCR2       /       
mice. TRAIL induction in alveolar exudate macrophages 
may be caused by the recruitment process into the lung itself 
or by infl  ammatory mediators present within the IV-infected 
alveolar compartment. Notably, TRAIL induction on re-
cruited macrophages was observed in PR/8 infection, repre-
senting a very severe and highly infl  ammatory form of IV 
pneumonia in mice, but not in x31 infection, suggesting that 
TRAIL-mediated alveolar injury might be restricted to se-
vere forms of IV pneumonia as observed during human 
H5N1 infections. Consistent with this, previous reports iden-
tifi  ed type I IFNs as potent inducers of TRAIL in monocytes 
and DCs (  21, 37  ). Indeed, we found IFN-      to be alveolar 
released upon PR/8 infection in WT mice yet peaking early 
by day 2 pi (219   ±   78 pg/ml; unpublished data). TRAIL, 
acting as a membrane-bound or soluble form, has been 
known to induce apoptosis in various tumor cells but not in 
nonneoplastic cells (  20, 21  ). Recently, TRAIL expressed 
on lymphocyte subpopulations, DCs, and monocyte-derived 
macrophages has been associated with antiviral host responses 
during IV infection (  17, 18, 38  ), underlining the importance 
of death pathways in antiviral immunity. In contrast, Wurzer 
et al. (  39  ) found TRAIL-induced programmed cell death 
pathways to be crucial for IV propagation in vitro. In mice, 
TRAIL exclusively acts via the membrane DR5 that is ex-
pressed on the target cell. Interestingly, DR5 was up-regulated 
in primary murine AECs in vitro and in vivo upon PR/8 in-
fection, suggesting that a preceding epithelial IV infection 
might facilitate TRAIL-induced apoptosis as a potential host 
mechanism to limit viral spread. Indeed, in our model, PR/8 
clearance revealed to be delayed in mice upon anti-TRAIL 
treatment. However, DR5 expression was also detectable in 
uninfected epithelial cells, indicating that exudate macro-
phage TRAIL may have the potential to attack noninfected 
epithelial cells as well when released in large amounts. JEM VOL. 205, December 22, 2008 
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wash out alveolar leukocytes and were thereafter slowly infl  ated with 1.5 ml 
of a 1:1 mixture of Tissue-Tek OCT (Sakura) and PBS       /      , removed en 
bloc, and snap frozen in liquid nitrogen. Lung tissue cryosections were 
mounted on glass slides and dried overnight at room temperature. Apoptotic 
cells were stained using the DeadEnd Colorimetric TUNEL system (Pro-
mega) according to the manufacturer  ’  s instructions. Slides were analyzed 
with a light microscope (DM 2000; Leica) at the indicated magnifi  cation us-
ing digital imaging software (Leica). 
  RNA isolation and real time RT-PCR.     RNA from sorted blood or 
BAL cells was isolated using the RNeasy Micro kit (QIAGEN), whereas 
RNA from cultured AECs was isolated by PeqGOLD Total RNA kit 
(PEQLAB) according to the manufacturer  ’  s instructions. For cDNA synthe-
sis, reagents and incubation steps were performed as described previously (  2  ). 
Reactions were performed in an ABI 7900 Sequence Detection System (Ap-
plied Biosystem) using SYBR  –  Green I as fl  uorogenic probe in 25-  μ  l reac-
tions containing 5   μ  l cDNA sample, Platinum SYBR Green qPCR Super-
Mix (Invitrogen), and 45 pmol of forward and reverse primers. The following 
primer sequences were used: TNF-      forward, 5     -CATCTTCTCAA-
AATTCGAGTGACAA-3     , and reverse, 5     -TGGGAGTAGACAAGG-
TACAACCC-3     ; FasL forward, 5    -CCAACCAAAGCCTTAAAGTAT-
CATC-3     , and reverse, 5     -AACCCAGTTTCGTTGATCACAA-3     ; 
TRAIL forward, 5    -GAAGACCTCAGAAAGTGGC-3     , and reverse, 5    -GA  C-
CAGCTCTCCATTCCTA-3     ; DR5 forward, 5     -AAGTGTGTCTC-
CAAAACGG-3     , and reverse, 5     -AATGCACAGAGTTCGCACT-3     ; and 
PBGD forward, 5     -GGTACAAGGCTTTCAGCATCG-3     , and reverse, 
5     -ATGTCCGGTAACGGCGGC-3     . Relative expression was determined 
by the 2            Ct   method. 
  AEC isolation and infection.     AECs were isolated from untreated WT 
mice, cultured for 5 d, and infected with infl  uenza A virus at the indicated 
multiplicity of infection for 8 h as previously described in detail (  4  ). 
  Adoptive transfer of PBMC.     For isolation of PBMCs, whole blood cells 
gained from WT, TRAIL       /      , or CCR2       /       mice were carefully layered 
over 3 ml Lympholyte (Biozol). Cells were centrifuged at 1,400 rpm at room 
temperature for 35 min to separate the mononuclear fraction. The interphase 
was collected and mononuclear cells were washed twice in RPMI 1640. 2   ×   
10  6   MNC in 150   μ  l RPMI were injected i.v. directly before PR/8 infection 
into CCR2       /       mice. Purity of MNC was always   >  90%, as assessed by dif-
ferential counts on Pappenheim-stained cytocentrifuge preparations. 
  Statistical analysis.     All data are given as the mean   ±   SD. For analysis of 
statistical diff   erences, one-factor ANOVA was applied. Statistical signifi  -
cances between treatment groups were calculated with the SPSS for Win-
dows software program (SPSS, Inc.). Signifi  cance was assumed when P values 
were   <  0.05. 
  Online supplemental material.     Fig. S1 shows the time course of in-
terstitial lung exudate macrophage proportions in PR/8-infected WT 
and CCR2-defi  cient mice. Fig. S2 shows the time course of viral titers 
in lung homogenate of PR/8-infected untreated or anti-TRAIL  –  treated 
WT mice. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20080201/DC1. 
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Mice were bred under specifi  c pathogen-free conditions. All experiments 
were approved by the regional council (Regierungspr  ä  sidium) of Giessen. 
  Treatment protocols.     Mice were intratracheally inoculated with 500 
PFU of IV PR/8 (A/PR/8/34; H1N1) or with 50,000 PFU of A/HKx31 
(x31; H3N2) diluted in sterile PBS       /       in a total volume of 70   μ  l or mock-
infected with PBS       /       alone, and blood and BAL leukocytes were gained 
and processed as previously outlined in detail (  44  ). BAL cells were counted 
with a hemocytometer, and diff  erential cell counts of Pappenheim-stained 
cytocentrifuge preparations were performed using overall morphological 
criteria, including diff  erences in cell size and shape of nuclei. Alveolar leak-
age in treated mice was analyzed by the lung permeability assay by i.v. injec-
tion of FITC-labeled albumin as previously described (  2  ). For apoptosis 
detection, perfused lungs from infected or mock-infected mice were di-
gested as previously outlined in detail (  4  ), washed, and resuspended in FACS 
buff  er (PBS, 7.4% EDTA, and 0.5% FCS). For quantitative analysis of inter-
stitial exudate macrophages, lavaged and perfused lung tissue from WT or 
CCR2-defi  cient mice was prepared as previously described (  2  ) and resus-
pended in FACS buff  er. 
  Lung virus titers.     Lungs were mechanically homogenized in 2 ml PBS  +/+   
on ice and centrifuged at 4,000 rpm for 10 min at 4  °  C, and supernatants were 
serially diluted (1:10  0   to 1:10  7  ) in PBS/BA containing 0.2% BSA, 1 mM 
MgCl  2  , 0.9 mM CaCl  2  , 100 U/ml of penicillin, and 0.1 mg/ml of strepto-
mycin. Virus titers were determined by immunohistochemistry on confl  uent 
Madin-Darby canine kidney cells in 96-well plates in duplicates. In brief, 
cells were incubated with 50   μ  l of homogenate dilution for 1 h at room tem-
perature and covered with 1.5% methylcellulose media containing 2   μ  g/ml 
trypsin (PAA) for 72 h. Cells were permeabilized and fi  xed with PBS  +/+  /4% 
PFA/1% Triton X-100, incubated with diluted primary anti-PR/8 nucleo-
protein mAb (Biozol) and secondary HRP-conjugated anti  –  mouse antibody 
for 45 min each, and stained with an AEC staining kit (Sigma-Aldrich) for 
10 min. Foci were counted using a light microscope (DM 2500; Leica). 
  Flow cytometry and cell sorting.     1  –  5   ×   10  5   PFA-fi  xed cells were washed 
in either FACS or annexin V staining buff  er (10 mM Hepes, 140 mM NaCl, 
and 2.5 mM CaCl  2  ), incubated with the respective primary and secondary 
mAbs, and fl  ow cytometric analysis was performed using a FACSCanto fl  ow 
cytometer (BD) as previously described (  2  ). Cells stained with primary 
CCR2 mAb were coupled with biotinylated F(ab     )  2   anti-Ig for 30 min be-
fore a 15-min incubation with Streptavidin-PE. For cell sorting experiments, 
unfi  xed blood or BAL cells from eight mice per experiment were incubated 
with the given mAbs and high purity sorted with a FACSVantage SE fl  ow 
cytometer as previously outlined in detail (  2  ). Purities of sorted cell popula-
tion were always   >  90%. 
  ELISA.     Cytokine levels from BALF were analyzed using commercially 
available ELISA kits (R  &  D Systems) according to the manufacturer  ’  s in-
structions. Detection limits were 2 pg/ml for CCL2, 5.1 pg/ml for TNF-     , 
and 12.5 pg/ml for IFN-     . 
  Creation of BM chimeric mice.     BM cells were isolated under sterile 
conditions from the tibias and femurs of WT C57BL/6 or from CCR2       /       
or TRAIL       /       donor mice as described previously (  25  ). In some experi-
ments, WT and CCR2       /       BM cells were mixed at a 1:1 ratio before trans-
plantation. As controls for BM engraftment, WT C57BL/6 BM cells 
(expressing the CD45.2 alloantigen) were transplanted into CD45.1 alloan-
tigen-expressing C57BL/6 mice (  n   = 2 during each transplantation experi-
ment), and the proportion of CD45.2-positive peripheral blood leukocytes 
was analyzed by fl  ow cytometry. BM engraftment was 90.5   ±   2.7% 2 wk af-
ter transplantation. Chimeric mice were housed under specifi  c pathogen-
free conditions for 14 d before PR/8 infection. 
  Preparation of lung tissue sections and TUNEL assay.     Perfused lungs 
were carefully lavaged with 400-  μ  l aliquots of PBS       /      /2 mM EDTA to 3076 MACROPHAGES AND ALVEOLAR EPITHELIAL APOPTOSIS   | Herold et al. 
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